EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links


[Gastric cancer 704 - ¸Õ ±æÀ» µ¹°í µ¹¾ÒÁö¸¸ °á±¹ °¡À̵å¶óÀο¡ µû¸¥ Á¤È®ÇÑ Ä¡·á°¡ µÇ¾ú´ø Áõ·Ê]

Previous | Next

001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000


Àα٠°ËÁø±â°ü ³»½Ã°æ¿¡¼­ À§¾Ï ÀÇ½É º´¼Ò°¡ ¹ß°ßµÇ¾ú°í Á¶Á÷°Ë»ç °á°ú ¡°atypical gland, highly suspicious for adenocarcinoma, W/D¡±·Î ³ª¿Í ÀÇ·ÚµÈ 60´ë ÃÊ¹Ý ¿©¼ºÀÔ´Ï´Ù. (2016³â)

À§¾ÏÀÏ °ÍÀ¸·Î »ý°¢µÇ°í À§¾ÏÀÌ¸é ¼ö¼úÀÌ ÇÊ¿äÇÏ´Ù°í ¸»¾¸µå·È½À´Ï´Ù. Total gastrectomy ȤÀº proximal gastrectomy with double tract reconstructionÀ» ¼³¸íµå·È½À´Ï´Ù.

ȯÀÚ´Â ³î¶ó¼­ º» º´¿ø¿¡¼­ °Ë»ç Á¶Â÷ ¹ÞÁö ¾Ê°í ´Ù¸¥ ÀÇ·á±â°üÀ» ¹æ¹®ÇÏ¿© ESD¸¦ ¹ÞÀ¸¼Ì½À´Ï´Ù. ESD °á°ú ¡°TA (P/D with marked lymphocyte infiltration), 2.8cm, SM2 (900um), lymphovascular invasion (+)¡±ÀÌ ³ª¿Í ESD¸¦ ¹ÞÀº º´¿ø ¿Ü°ú¿¡¼­ ¼ö¼úÀ» °èȹÇÏ¿´À¸³ª 2Â÷ ÀÇ°ßÀ» À§ÇÏ¿© ´Ù½Ã Àú¸¦ ã¾Æ¿À¼Ì½À´Ï´Ù.

¾Æ·¡¿Í °°ÀÌ ¼³¸íµå·È½À´Ï´Ù.

"XX´ë¿¡¼­ Ä¡·á¸¦ ¹ÞÀ¸¼Ì°í ºñ±³Àû ÀÛÀº Á¶±âÀ§¾ÏÀ¸·Î ÆǴܵǾî 85% Á¤µµÀÇ Ãʱ⼺°ø·ü (³»½Ã°æÄ¡·á¸¸À¸·Î ÀÏÂ÷ Ä¡·á°¡ ³¡³ª´Â ºñÀ²)À» ¿¹ÃøÇÏ´Â »óȲ¿¡¼­ ³»½Ã°æÄ¡·á¸¦ ¹ÞÀ¸¼ÌÀ» °ÍÀε¥ ¾Æ½±°Ôµµ ±× 85%¿¡ µéÁö ¸øÇÏ°í ¼ö¼úÀÌ ÇÊ¿äÇÑ 15%¿¡ ÇØ´çÇÏ´Â °á°ú°¡ ³ª¿Ô½À´Ï´Ù. ³»½Ã°æÀ¸·Î ÀýÁ¦ÇÑ Ç¥º»¿¡ ´ëÇÑ ÃÖÁ¾ º´¸®°á°ú¿¡¼­ ¼¼Æ÷Çü, ±íÀÌ, ¹üÀ§, ¸²ÇÁ°ü/Ç÷°ü¿¡ ¸ðµÎ ¹®Á¦°¡ ¾ø¾î¾ß Çϴµ¥ ¾Æ½±°Ôµµ ¼¼Æ÷°¡ ³ª»Ú°í ±íÀº °ÍÀ¸·Î ³ª¿Ô½À´Ï´Ù. Áï ¼ö¼úÀÌ ÇÊ¿äÇÑ °ÍÀ¸·Î ³ª¿Ô½À´Ï´Ù. ÀÌ·± ºÐµéÀÌ ¾à 15%Á¤µµ µË´Ï´Ù.

º´¸®°á°ú¿¡ ¹®Á¦°¡ ¾øÀ» ¶§ Àç¹ß·üÀÌ 5% Á¤µµÀε¥ ¹ÝÇÏ¿©, ÇöÀçÀÇ Àç¹ß À§ÇèÀº 10-20% ÀÌ»óÀÔ´Ï´Ù. ¸¸¾à Àç¹ßÇϸé Àý¹Ý ÀÌ»óÀº ¿ÏÄ¡ÀÇ ±âȸ°¡ ¾ø½À´Ï´Ù. µû¶ó¼­ ¼ö¼úÀÌ °æ°ú°üÂûº¸´Ù À¯¸®ÇÑ »óȲÀÔ´Ï´Ù. ¹°·Ð ¼ö¼úÀº ¼ö¼úÀÔ´Ï´Ù. Àü½Å¸¶Ãë¿¡ µû¸¥ À§Çè, ÅëÁõ, ¼ö¼úÀÇ ÇÕº´Áõ, ¼ö¼ú ÈÄ »îÀÇ Áú ÀúÇÏ µîÀÇ ¾î·Á¿î Á¡ÀÌ ÀÖÁö¸¸ ±×·¡µµ Àç¹ßÀ§ÇèÀ» ´õ ¸¹ÀÌ °í·ÁÇØ¾ß ÇÑ´Ù°í ÆǴܵ˴ϴÙ. ÇöÀç ¾ÏÀÌ ³²¾ÆÀÖ´Ù´Â Áõ°Å°¡ ÀÖ¾î ¼ö¼úÀ» ±ÇÇÏ´Â °ÍÀº ¾Æ´Õ´Ï´Ù. ´ÜÁö Àç¹ßÀ§ÇèÀÌ ³ô±â ¶§¹®ÀÔ´Ï´Ù. ¼ö¼úÀ» Çغ¸¸é ´«¿¡ º¸ÀÏ Á¤µµÀÇ ¾ÏÀÌ ³²¾ÆÀÖ´Â °æ¿ì´Â 10-20% Á¤µµÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ³»¿ëÀ» ¸ðµÎ Á¾ÇÕÇÏ¿© ÆÇ´ÜÇÒ ¶§ ¼ö¼úÀ» ±ÇÇÏ°í ½Í½À´Ï´Ù. ¿Ü°ú ÀÇ·Ú¸¦ ÇÏ°Ú½À´Ï´Ù. ±¸Ã¼ÀûÀÎ ¼ö¼ú ¹æ¹ýÀº ¿Ü°úÀÇ»ç¿Í »óÀÇÇϽñ⠹ٶø´Ï´Ù."

Total gastrectomy¸¦ ¹ÞÀ¸¼Ì°í ¾Æ·¡ÀÇ °á°ú¿´½À´Ï´Ù.

Stomach, radical total gastrectomy: Status post endoscopic submucosal dissection at outside hospital
No residual tumor
1) Location: cannot be determined (no residual tumor)
2) Gross type: cannot be determined (no residual tumor)
3) Histologic type: cannot be determined (no residual tumor)
4) Histologic type by Lauren: cannot be determined (no residual tumor)
5) Size: cannot be determined (no residual tumor)
6) Depth of invasion: cannot be determined (no residual tumor)
7) Resection margin: free from carcinoma
8) Lymph node metastasis : no metastasis in 43 regional lymph nodes (pN0)
9) Lymphatic invasion: not identified
10) Venous invasion: not identified
11) Perineural invasion: not identified
12) Peritoneal cytology: negative

¸Õ ±æÀ» µ¹°í µ¹¾ÒÁö¸¸ °á±¹ °¡À̵å¶óÀο¡ µû¸¥ Á¤È®ÇÑ Ä¡·á°¡ µÇ¾ú´Ù°í »ý°¢ÇÕ´Ï´Ù. ¹«Áõ»ó ȯÀÚµéÀÌ ¼ö¼úÀ», ±×°Íµµ total gastrectomy¸¦ ¹Þ¾ÆµéÀÌ´Â °ÍÀº ½¬¿î ÀÏÀÌ ¾Æ´Ñ ¸ð¾çÀÔ´Ï´Ù. ºñ½ÁÇÑ È¯ÀÚ°¡ »ó´çÈ÷ ¸¹½À´Ï´Ù.

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng. (2018-12-18)